What to know about oneida hollowarens new medicine

Two of the five oneida children with rare lung disease are being treated in the new medical facility at the Oneida Medical Center in Oneida, New York, according to state health officials.

Two of the children with the rare lung disorder have been transferred to the facility.

The children were hospitalized last week for treatment, and doctors say they are expected to make a full recovery.

They were among the five children who had lung disease when they arrived in New York City last week, and were given one month of lung therapy.

According to health officials, the children were diagnosed with Lusotrigib, a drug used to treat chronic bronchitis and other conditions, and are expected “to make a complete recovery.”

The treatment, which the children received last week in New Jersey, has already been approved by the Food and Drug Administration.

Lusotrib, which has been approved for use in children with chronic bronchiectasis, was also approved by New Jersey to treat rare lung diseases.

A source close to the children told Fox News that doctors at Oneida said they are not sure if the children will need to take more medications and if they will need additional tests.

“We’re not certain they will have to take any more medications for sure,” the source said.

“We are not certain how long the kids will be in the facility.”

A source at the Children’s Hospital in New Brunswick told Fox New that doctors there told the children that they will likely be transferred to another facility, and that they were “not sure” if the hospital will have any more children who may need lung treatment.